Skip to main content

Events2

sepsis awareness month
Vivacelle Bio’s President and Chief Innovation Officer to Present Data Highlighting the Company’s Late-Stage Clinical Programs at the BIO International Convention 2024 EventsPress Release

Vivacelle Bio’s President and Chief Innovation Officer to Present Data Highlighting the Company’s Late-Stage Clinical Programs at the BIO International Convention 2024

Vivacelle is advancing a robust pipeline of therapies for shock and trauma-induced conditions Vivacelle's pipeline is led by VBI-S, a Phase 3-ready asset designated for the treatment of hypotension and…
Kendra Webb-Scott
May 31, 2024